Cargando…
Emerging medical therapies for severe alcoholic hepatitis
Severe alcoholic hepatitis (AH) is an acute and often devastating form of alcohol-associated liver disease. Clinically, AH is characterized by elevated bilirubin, model for end stage liver disease scores >20, and nonspecific symptoms that are caused by underlying inflammation, hepatocyte injury,...
Autores principales: | Tornai, David, Szabo, Gyongyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641578/ https://www.ncbi.nlm.nih.gov/pubmed/32981291 http://dx.doi.org/10.3350/cmh.2020.0145 |
Ejemplares similares
-
A novel score of IL-13 and age predicts 90-day mortality in severe alcohol-associated hepatitis: A multicenter plasma biomarker analysis
por: Tornai, David, et al.
Publicado: (2023) -
Inhibition of Triggering Receptor Expressed on Myeloid Cells 1 Ameliorates Inflammation and Macrophage and Neutrophil Activation in Alcoholic Liver Disease in Mice
por: Tornai, David, et al.
Publicado: (2018) -
MicroRNA Signature in Alcoholic Liver Disease
por: Bala, Shashi, et al.
Publicado: (2012) -
Alcohol’s Contribution to Compromised Immunity
por: Szabo, Gyongyi
Publicado: (1997) -
Toll-Like Receptors in the Pathogenesis of Alcoholic Liver Disease
por: Petrasek, Jan, et al.
Publicado: (2010)